Abstract
Chronic meningitis can be a diagnostic dilemma for even the most experienced clinician. Many times, the differential diagnosis is broad and encompasses autoimmune, neoplastic, and infectious etiologies. This review will focus on a general approach to chronic meningitis to simplify the diagnostic challenges many clinicians face. The article will also review the most common etiologies of chronic meningitis in some detail including clinical presentation, diagnostic testing, treatment, and outcomes. By using a case-based approach, we will focus on the key elements of clinical presentation and laboratory analysis that will yield the most rapid and accurate diagnosis in these complicated cases.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Ellner JJ, Bennett JE. Chronic meningitis. Medicine (Baltimore). 1976;55:341–69.
Bisbe J et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis Off Publ Infect Dis Soc Am. 1992;15:910–23.
Martínez-Vázquez C et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis Off Publ Infect Dis Soc Am. 1998;27:1130–3.
Treatment of tuberculosis: guidelines. World Health Organization 4th edition. Geneva; 2010.
Thwaites GE, Chau TTH, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol. 2004;42:378–9.
Stewart SM. The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol. 1953;6:241–2.
Zunt JRM, Baldwin KJ. Chronic and subacute meningitis. [Review]. Contin Lifelong Learn Neurol. 2012;18:1290–318.
U.S. Preventive Services Task Force. Screening for syphilis infection: recommendation statement. Ann Fam Med. 2004;2:362–5.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Tickborne diseases of the United States: a reference manual for health care providers, Third edition, 2015; 2015. at <http://stacks.cdc.gov/view/cdc/30740>.
Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am. 2015;29(2):241–53.
Wormser GP et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134.
Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995;8:515–48.
Perfect JR et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322.
Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis. 2014;58:113–6.
Day JN. Cryptococcal meningitis. Pract Neurol. 2004;4:274–85.
Charlier C et al. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS ONE. 2008;3, e1950.
Graybill JR et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis Off Publ Infect Dis Soc Am. 2000;30:47–54.
Wilson MR et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370:2408–17. Depicts rapid diagnosis with NGS in a child with worsening idiopathic chronic meningitis. Treatment was instituted after detection leading to resolution.
Naccache SN et al. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis. 2015;60:919–23. Demonstrates a case with discovered diagnosis of rare virus that would never had been previously tested in meningitis cases using NGS.
Quan PL et al. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis. 2010;16:918–25.
Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173:707–17.
Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol. 2002;33:116–24.
Herbrecht R et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20:1898–906.
Herbrecht R et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.
Walsh TJ et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.
Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996;22 Suppl 2:S102–111.
Wheat LJ et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45:807–25.
Bariola JR et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis. 2010;50:797–804.
Chapman, SW. in Principles and practice of infectious diseases (eds. Mandell, G. L., Douglas, R. G. & Bennett, J. E.) 3026–3040 Churchill Livingstone; 1990.
Chapman SW et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801–12.
Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;42:103–7.
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65.
Carlson ML et al. Cranial base manifestations of neurosarcoidosis: a review of 305 patients. Soc Eur Acad Otol Neurotol. 2015;36:156–66.
Zajicek JP et al. Central nervous system sarcoidosis—diagnosis and management. QJM Mon J Assoc Physicians. 1999;92:103–17.
Ginsberg L, Kidd D. Chronic and recurrent meningitis. Pract Neurol. 2008;8:348–61.
Williams PL et al. Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis. J Infect Dis. 2002;186:1692–5.
Bañuelos AF et al. Central nervous system abscesses due to Coccidioides species. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996;22:240–50.
Galgiani JN et al. Coccidioidomycosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41:1217–23.
Lynch JP. Neurosarcoidosis: how good are the diagnostic tests? J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc. 2003;23:187–9.
Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5:443–52.
Chowdhary S, Chamberlain M. Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Cancer Netw JNCCN. 2005;3:693–703.
Chamberlain MC. Neoplastic meningitis. Oncologist. 2008;13:967–77.
Kaplan JG et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol. 1990;9:225–9.
Garg RK, Sinha MK. Tuberculous meningitis in patients infected with human immunodeficiency virus. J Neurol. 2011;258:3–13.
Thwaites GE et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol. 2004;42:996–1002.
Prasad, K. & Singh, M. B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst. Rev. CD002244. 2008. doi:10.1002/14651858.CD002244.pub3.
Baldwin KJ, Zunt JR. Evaluation and treatment of chronic meningitis. Neurohospitalist. 2014;4:185–95. Clinical approach to chronic meningitis.
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64(RR-03):1–137.
Marra CM et al. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis. 2012;39:453–7.
García P et al. Laboratory diagnosis of Treponema pallidum infection in patients with early syphilis and neurosyphilis through a PCR-based test. Rev Chil Infectol Órgano Soc. 2011;28:31–315.
Halperin JJ. Lyme disease: a multisystem infection that affects the nervous system. Contin Minneap Minn. 2012;18:1338–50.
Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology. 1996;46:619–27.
Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis. 1990;161:1203–9.
Nocton JJ et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis. 1996;174:623–7.
Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571–82.
Day JN et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291–302.
Gwak HS et al. Recent advancements of treatment for leptomeningeal carcinomatosis. J Korean Neurosurg Soc. 2015;58(1):1–8.
Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979;29:1369–75.
Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49:759–72.
Taylor JW et al. Primary leptomeningeal lymphoma. Neurology. 2013;81(19):1690–6.
Smith JE, Aksamit AJ. Outcome of chronic idiopathic meningitis. Mayo Clin Proc. 1994;69:548–56.
Naccache SN et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014;24:1180–92. Rapid diagnosis with a new informatics pipeline that compares DNA results to database of living organisms.
Schubert RD, Wilson MR. A tale of two approaches: how metagenomics and proteomics are shaping the future of encephalitis diagnostics. Curr Opin Neurol. 2015;28:283–7.
Calistri A, Palù G. Editorial commentary: unbiased next-generation sequencing and new pathogen discovery: undeniable advantages and still-existing drawbacks. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60:889–91.
Siva A et al. Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 2001;248:95–103.
Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet’s syndrome. Brain J Neurol. 1999;122(Pt 11):2183–94.
Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet Lond. Engl. 1990;335:1078–80.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Infection
Rights and permissions
About this article
Cite this article
Baldwin, K., Whiting, C. Chronic Meningitis: Simplifying a Diagnostic Challenge. Curr Neurol Neurosci Rep 16, 30 (2016). https://doi.org/10.1007/s11910-016-0630-0
Published:
DOI: https://doi.org/10.1007/s11910-016-0630-0